Navigation Links
Monsanto's R&D Pipeline Set to Deliver Valuable Products to Farmers Well Into Next Decade
Date:1/8/2008

ST. LOUIS, Jan. 8 /PRNewswire-FirstCall/ -- Substantial progress and momentum behind its research-and-development (R&D) pipeline has Monsanto (NYSE: MON) poised to deliver several new blockbuster products to farmers by 2012, company leaders will tell investors today. The remarks will come as part of a series of presentations on the company's R&D pipeline in New York and Boston.

"It's rewarding to see such innovation in the pipeline right now," said Steve Padgette, vice president of biotechnology for Monsanto. "This is the most progress I've seen in my 23 years at the company. Our data demonstrates these cutting-edge innovations can deliver new value to farmers well into the next decade."

As part of the presentations, scheduled over the next two days, Padgette will discuss the progress and momentum behind a number of key projects in the R&D pipeline. Key highlights include:
-- YieldGard VT PRO, one of the primary components of SmartStax

technology, is primed to offer farmers a broader spectrum of insect

control and improved durability when compared with the company's

first-generation corn borer offering. The second-generation corn borer

technology is in Phase IV of the company's R&D pipeline and currently

awaiting regulatory approvals.

-- YieldGard Rootworm III is designed to provide two modes of action for

improved spectrum control and enhanced durability against the corn

rootworm pest. The technology incorporates cutting-edge RNA

interference (RNAi) technology and novel protein identification. RNAi

is a mechanism used naturally by cells to regulate gene expression. By

harnessing this natural machinery, RNAi technology c
'/>"/>

SOURCE Monsanto
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline
2. Lighting the Onco-Pipeline, Stem Cell Cancer, and More at Global Cancer Congress, January 28-29, 2008, Tampa
3. Michigan Life Sciences Pipeline to Kick Off MichBio Expo
4. Clinical and Economical Considerations For IV Push Drug Delivery by Industry Expert Richard Rosenfeld Is Now Accessible on Expert411.com for Media and Professional Use
5. Cell Genesys Announces Sale of Lentiviral Gene Delivery Technology for $12 Million
6. Delivering Molecular Imaging Solutions Across Clinical Specialties: Siemens Showcases New Technologies at RSNA 2007
7. BAI Retail Delivery Conference Softpro Presents Next Generation Signature Tablet
8. Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington
9. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
10. CompareNetworks Media Group Delivers CME/CE Through Acuity Medical Education
11. PARI Respiratorys LC PLUS & PRONEB Ultra Deliver Dey, L.P.s New COPD Therapy; Perforomist Launched Yesterday
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)... Total impact of NC,s biotechnology sector is $45....LE PARK, N.C., Nov. 20 ...n its expanding biotechnology enterprise during th...ceeds $45 billion, according to data released toda... , Norris Tolson, president and CEO of the Bio...
(Date:11/20/2008)... SAN DIEGO, Nov. 20 Neur...ced today that Kevin Gorman, President and Chief,...e presenting at the 20th,Annual Piper Jaffray Hea... "fireside chat" presentation takes place Tuesday,.../10:30 a.m. Pacific Time (PT). The,presentation w...
(Date:11/20/2008)... LENEXA, Kan., Nov. 20 KansasBio a...itiative to promote the region,s human,health-car...re drug,development continuum. Called the Nationa... the alliance comprises companies across Kansas an...t many of the nation,s preferred resources,for dr...
(Date:11/20/2008)... LONGMONT, Colo., Nov. 20 MicroPha...unced it has concluded its latest round,of financ...ion. Investors in,this round were a combination ... have come from private investors. , MicroP...ete the validation,and launch preparation of thei...
Breaking Biology Technology:North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 2North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 3North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 4North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 5National Drug Development Accelerator Launched 2MicroPhage Closes Latest Financing 2
... Sharon, Wis. - Global Renewable LLC, a Whitewat...mmy Thompson , has unveiled plans to build and ope...County Village of Sharon . , ,Pending municipal a...produce between 105 and 120 million gallons of eth...e jobs and more than 200 temporary construction jo...
... Wausau, Wis. - The Wisconsin Innovation Networ... a partially untapped economic development resourc... meeting, to be held at the Wausau Business Develo...ghout north central Wisconsin will have an opportu...sity resources to the benefit of their organizatio...
... Green Bay, Wis. - Valuable business advice and ...consin economic development organizations hold the... , ,The competition is open to any start-up busine...tion, in northeastern Wisconsin. In addition to ca...d, entrepreneurs will receive advice about craftin...
... Madison, Wis. - The notion of improving busines... is hardly new, but one local expert believes the ...ant business leaders need an education in Web 2.0....uted to a lack of information. Building on Interne...at is Web 2.0? " bloggers like Dion Hinchcliffe ,...
Other Biology Technology:Businesses are slow to adopt Web 2.0 concepts 2Businesses are slow to adopt Web 2.0 concepts 3Businesses are slow to adopt Web 2.0 concepts 4
(Date:11/21/2008)...mber 21, 2008A prestigious group of physicians, nu...in Williamsburg, VA on March 27-29, 2009 at the Wi...rmation on cutting-edge therapeutic protocols, nov...advances that impact patient care. The full progra...ation is available at www.bioconferences.com/wh ...
(Date:11/21/2008)...c Barbara Ann Halkier, Department of Plant Biology..., University of Copenhagen, has been granted the D...ard for her excellent research into secondary meta...in, for instance, plants. In particular, her rese...ion and transport of glucosinolates in cruciferous...
(Date:11/20/2008)... 19 DigitalPersona, Inc., the,lea...nced DigitalPersona,Personal 4.0, an easy-to-use ...,members and business users. DigitalPersona Person...use biometrics, letting people use their fingerpri... banking, shopping, and other Web,sites -- to pro...
(Date:11/20/2008)...0, 2008 -- A team led by Thomas Schulthess of the ...oratory received the prestigious 2008 Association ...ursday after attaining the fastest performance eve...Schulthess is group leader of ORNL,s Computational...osition as director of the Swiss National Supercom...
Breaking Biology News(10 mins):17th Annual Congress on Women's Health convenes 2The Danisco Award 2008 goes to D.Sc. Barbara Ann Halkier from Faculty of Life Sciences, Copenhagen 2DigitalPersona Places Identity Protection at People's Fingertips 2DigitalPersona Places Identity Protection at People's Fingertips 3ORNL supercomputer simulation wins prize for fastest-running science application 2ORNL supercomputer simulation wins prize for fastest-running science application 31st EMEA application filed for product using innovative intradermal microinjection system BD Soluvia 11833 11st EMEA application filed for product using innovative intradermal microinjection system BD Soluvia 11833 2Aspen Health Stewardship Project Provides Means for Presidential Candidates to Reframe Health Care Reform 11830 1Aspen Health Stewardship Project Provides Means for Presidential Candidates to Reframe Health Care Reform 11830 2Aspen Health Stewardship Project Provides Means for Presidential Candidates to Reframe Health Care Reform 11830 3Sun Busters 28R 29 Now Sports The Skin Cancer Foundations Seal of Recommendation 11826 1Sun Busters 28R 29 Now Sports The Skin Cancer Foundations Seal of Recommendation 11826 2Sun Busters 28R 29 Now Sports The Skin Cancer Foundations Seal of Recommendation 11826 32008 Georgia Walk for Autism Supporters Gather in Atlanta for Kick Off Dinner 11823 12008 Georgia Walk for Autism Supporters Gather in Atlanta for Kick Off Dinner 11823 2
...n body deal with injury better than others. A fles...ou are otherwise healthy, both will heal. The prog...t so clear-cut. , It has long been thought that ca... self-renewal and repair, impeding the chances of ...nt evidence suggests that the heart might harbor s...
...oday announced the grant of a major patent, US # 6...k Office on microarray products allowing the speci...icing, covering microarrays optimised for the disc...nt protects the probe configuration of a unique se...ch splice variant. There are many applications for...
...esults in irreversible damage to the heart that ca...ge results from the limited ability of the myocard... and colleagues from Tufts University now document... of human bone marrow–derived stem cells with ther... following myocardial infarction. , In their study...
...tal ball. A new approach to predict whether a drug...s best could get antibiotics to market faster and ...s. , In recent years, scientists worldwide have so...to combat bad bugs. Bacteria are increasingly adep.... , Yet designing and testing new antibiotics can...
Other Biology News:Heart repair gets new muscle 2Products containing specific probes for detecting alternative splice forms protected 2New Drugs For Bad Bugs: UF Approach Could Bolster Antibiotic Arsenal 2New Drugs For Bad Bugs: UF Approach Could Bolster Antibiotic Arsenal 3New Drugs For Bad Bugs: UF Approach Could Bolster Antibiotic Arsenal 4
Finnigan LTQ FT from Thermo Scientific
The Discovery Series PDQuest 2-D analysis software is used for imaging, analyzing, and databasing two-dimensional electrophoretic gels. The 10-user network license entitles ten users to access data f
Mouse monoclonal antibody raised against a partial recombinant JRKL. NCBI Entrez Gene ID = JRKL
Mouse monoclonal antibody to ST8SIA2 - ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2
Biology Products: